<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Urol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Urol</journal-id>
      <journal-title-group>
        <journal-title>BMC Urology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2490</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25430699</article-id>
      <article-id pub-id-type="pmc">4259161</article-id>
      <article-id pub-id-type="publisher-id">387</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2490-14-96</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A rare case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis caused by a novel dominant mutation in <italic>CACNA1S</italic>: features and prognosis after adrenalectomy</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Bo</given-names>
          </name>
          <address>
            <email>603323687@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>Yuan</given-names>
          </name>
          <address>
            <email>yangyuan@scu.edu.cn</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tu</surname>
            <given-names>Wenling</given-names>
          </name>
          <address>
            <email>1035791950@qq.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>Ying</given-names>
          </name>
          <address>
            <email>yingcaishen01@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Dong</surname>
            <given-names>Qiang</given-names>
          </name>
          <address>
            <email>dqiang418@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Urology, West China Hospital, Sichuan University, Chengdu, 610041 China </aff>
        <aff id="Aff2"><label/>Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, 610041 China </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>28</day>
        <month>11</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>14</volume>
      <elocation-id>96</elocation-id>
      <history>
        <date date-type="received">
          <day>1</day>
          <month>5</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Yang et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Acute hypokalaemic paralysis is characterised by acute flaccid muscle weakness and has a complex aetiological spectrum. Herein we report, for the first time, a case of unilateral adrenal hyperplasia accompanied by hypokalaemic periodic paralysis type I resulting from a novel dominant mutation in <italic>CACNA1S</italic>. We present the clinical features and prognosis after adrenalectomy in this case.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A 43-year-old Han Chinese male presented with severe hypokalaemic paralysis that remitted after taking oral potassium. The patient had suffered from periodic attacks of hypokalaemic paralysis for more than 20&#xA0;years. A computed tomography (CT) scan of the abdomen showed a nodular mass on the left adrenal gland, although laboratory examination revealed the patient had not developed primary aldosteronism. The patient underwent a left adrenalectomy 4&#xA0;days after admission, and the pathological examination further confirmed a 1.1&#xA0;cm benign nodule at the periphery of the adrenal gland. Three months after the adrenalectomy, a paralytic attack recurred and the patient asked for assistance from the Department of Medical Genetics. His family history showed that two uncles, one brother, and a nephew also had a history of periodic paralysis, although their symptoms were milder. The patient&#x2019;s <italic>CACNA1S</italic> and <italic>SCN4A</italic> genes were sequenced, and a novel missense mutation, c.1582C&#x2009;&gt;&#x2009;T (p.Arg528Cys), in <italic>CACNA1S</italic> was detected. Detection of the mutation in five adult male family members, including three with periodic paralysis and two with no history of the disease, indicated that this mutation caused hypokalaemic periodic paralysis type I in his family. Follow-up 2&#xA0;years after adrenalectomy showed that the serum potassium concentration was increased between paralyses and the number and severity of paralytic attacks were significantly decreased.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We identified a novel dominant mutation, c.1582C&#x2009;&gt;&#x2009;T (p.Arg528Cys), in <italic>CACNA1S</italic> that causes hypokalaemic periodic paralysis. The therapeutic effect of adrenalectomy indicated that unilateral adrenal hyperplasia might make paralytic attacks more serious and more frequent by decreasing serum potassium. This finding suggests that the surgical removal of hyperplastic tissues might relieve the symptoms of patients with severe hypokalaemic paralysis caused by other incurable diseases, even if the adrenal lesion does not cause primary aldosteronism.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Unilateral adrenal hyperplasia</kwd>
        <kwd>Hypokalaemic periodic paralysis</kwd>
        <kwd>
          <italic>CACNA1S</italic>
        </kwd>
        <kwd>Adrenalectomy</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Adrenal hyperplasia (AH) is a common endocrine disease, and unilateral adrenal hyperplasia (UAH) is a common cause of primary aldosteronism (PA) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Muscular paralysis and decreased serum potassium are two of the initial symptoms in some patients with PA-causing UAH, which can be corrected by adrenalectomy [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. However, it is unclear whether adrenalectomy in patients with non-PA-causing UAH increases serum potassium, which would indicate that this surgery could relieve symptoms caused by hypokalaemia resulting from other incurable diseases.</p>
      <p>Hypokalaemic periodic paralysis (HOKPP), including HOKPP1 (OMIM #170400) and HOKPP2 (OMIM #613345), is a rare autosomal dominant inherited disease characterised by episodic muscle weakness with significant hypokalaemia (&lt; 0.9 to 3.0&#xA0;mmol/L) during attacks [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. HOKPP1 and HOKPP2 are caused by mutations in <italic>CACNA1S</italic> (calcium channel, voltage-dependent, L type, alpha 1S subunit) (OMIM #114208) and <italic>SCN4A</italic> (sodium channel, voltage-gated, type IV, alpha subunit) (OMIM #603967), respectively [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. The frequency of HOKPP attacks varies from daily to yearly, and the attacks typically last from 3&#x2013;4 hours up to a day or longer [<xref ref-type="bibr" rid="CR9">9</xref>]. The frequency of attacks varies significantly among members of families with HOKPP, and the cause for this variation remains unknown.</p>
      <p>In this case, we report the clinical features, diagnosis, and prognosis after adrenalectomy in a patient with non-PA-causing UAH and HOKPP and discuss the potential of this surgery to relieve the symptoms of hypokalaemic periodic paralysis.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 43-year-old male presented to the outpatient Department of Urology of West China Hospital in March 2012 with severe paralytic attacks characterised by palpitations and muscle weakness starting in the right thigh and spreading to all limbs. A significant reduction in the serum potassium concentration (1.89&#xA0;mmol/L, reference value 3.5&#x2013;5.0&#xA0;mmol/L) was found during laboratory examination, and an ECG indicated severe potassium deficiency. Symptoms remitted after taking oral potassium (50&#xA0;ml of 10% potassium chloride was administered immediately followed by an additional 50&#xA0;ml over 24&#xA0;h for a total dose of 10&#xA0;g). After the paralytic attack, a CT scan of the abdomen was performed, which revealed left UAH characterised by a nodular mass on the left adrenal gland. Laboratory examination showed a slight elevation in norepinephrine (602&#xA0;ng/L, reference value, 272&#x2013;559&#xA0;ng/L) and a reduction in adrenaline (&lt; 25&#xA0;ng/L, reference value 54&#x2013;122&#xA0;ng/L) in the serum. Other data, including the serum concentrations of potassium (3.71&#xA0;mmol/L), aldosterone (11.41&#xA0;ng/dL, reference value 9.8&#x2013;27.5&#xA0;ng/dl), cortisol (7.3&#xA0;&#x3BC;g/dL, reference value 7.2&#x2013;18.2&#xA0;&#x3BC;g/dL), renin (2.22&#xA0;ng/mL, reference value 0.56&#x2013;2.79&#xA0;ng/ml), calcium (2.27&#xA0;mmol/L, reference value 2.1&#x2013;2.7&#xA0;mmol/L), creatine kinase (58&#xA0;IU/L, reference value 19&#x2013;226&#xA0;IU/L), lactate dehydrogenase (167&#xA0;IU/L, reference value 110&#x2013;220&#xA0;IU/L), alanine aminotransferase (19&#xA0;IU/L, reference value &lt;55&#xA0;IU/L), aspartate transaminase (15&#xA0;IU/L, reference value &lt;46&#xA0;IU/L), creatinine (74.5&#xA0;&#x3BC;mol/L, reference value 53&#x2013;140&#xA0;&#x3BC;mol/L), blood urea nitrogen (7.69&#xA0;mmol/L, reference value 3.30&#x2013;8.22&#xA0;mmol/L), thyroid-stimulating hormone (6.3&#xA0;mU/L, reference value 2&#x2013;10&#xA0;mU/L), total-triiodothyronine (2.14&#xA0;nmol/L, reference value 1.8&#x2013;2.9&#xA0;nmol/L), and total thyroxine (87&#xA0;nmol/L, reference value 65156&#xA0;nmol/L), were normal. The patient did not have hypertension (117/83&#xA0;mm Hg).</p>
      <p>Patient history showed that the paralytic attacks were usually triggered by physical labour or stress and were periodic. Attack frequency varied from weekly during the summer to bimonthly in the winter; each attack lasted 4&#x2013;6 hours. This attack was the most severe of the attacks he had experienced during the past decade. Although these paralytic attacks were associated with hypokalaemia, the aetiology had not been previously established, and the patient had not received any treatment, including potassium supplement, between attacks. Two years before this attack, serum potassium had been measured several times between attacks; the results of three of these tests were available and were 3.74, 3.69 and 3.63&#xA0;mmol/L.</p>
      <p>Because of the presence of severe hypokalaemic periodic paralysis, the patient underwent a left adrenalectomy after admission. Examination of the adrenal gland revealed a 1.1-cm benign nodule at the periphery of the gland with multiple cortical nodular hyperplasias. The patient did not have any complications during the perioperative period and laboratory results were normal (serum potassium .87&#xA0;mmol/L, serum sodium 143.9&#xA0;mmol/L, norepinephrine 452&#xA0;ng/L, adrenaline 60&#xA0;ng/L, aldosterone 12.24&#xA0;ng/dL, cortisol 8.1&#xA0;&#x3BC;g/dL, renin 2.13&#xA0;ng/mL, creatine kinase 60&#xA0;IU/L, lactate dehydrogenase 168&#xA0;IU/L, alanine aminotransferase 20&#xA0;IU/L, aspartate transaminase 16&#xA0;IU/L, creatinine 81.3&#xA0;&#x3BC;mol/L, blood urea nitrogen 8.01&#xA0;mmol/L). He was discharged 4&#xA0;days after surgery. During the next 3&#xA0;months, while recovering at home, no paralytic attacks occurred. The patient then returned to work, and the acute paralytic crises soon recurred. A colour Doppler ultrasound examination did not show any abnormality of the right adrenal gland. The patient then asked for help from the Department of Medical Genetics. His serum potassium was monitored three times with a frequency of once per month with results of 4.12, 3.97, and 4.27&#xA0;mmol/L, respectively. As shown in Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>, in addition to the patient (II<sub>2</sub>), four other adult male family members, including two uncles (I<sub>5</sub> and I<sub>6</sub>), one brother (II<sub>3</sub>), and one nephew (III<sub>1</sub>), also had a history of paralytic attacks, although their attacks were milder and less frequent (yearly to decadal). These members refused examination to determine the presence or absence of UAH.<fig id="Fig1"><label>Figure 1</label><caption><p>
<bold>Mutation Detection of</bold>
<bold><italic>CACNA1S</italic></bold>
<bold>in the Family of Hypokalaemic Periodic Paralysis</bold>, <bold>Type I</bold>
<bold>(HOKPP1).</bold> Panel <bold>A</bold> shows the family pedigree with the patient as the proband (arrow). Panel <bold>B</bold> shows the DNA sequencing results of <italic>CACNA1S</italic> of the patient and a healthy control and the position of the c.1582C&#x2009;&gt;&#x2009;T heterozygous mutation (arrow). The mutation leads to an amino acid substitution of Arg for Cys at the 528th codon of CACNA1S.</p></caption><graphic xlink:href="12894_2014_387_Fig1_HTML" id="d30e358"/></fig></p>
      <p>Because of the positive family history of periodic paralysis with potential autosomal dominant inheritance, the diagnosis of HOKPP was considered, and genetic testing of the <italic>CACNA1S</italic> and <italic>SCN4A</italic> genes was performed using Sanger sequencing of all exons and their splice sites. Consequently, the patient was identified as a heterozygote carrying a novel missense mutation, c.1582C&#x2009;&gt;&#x2009;T, in <italic>CACNA1S</italic> (p.Arg528Cys) (Figure&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). In his family, the mutation was also detected in three other adult males with periodic paralysis (I<sub>6</sub>, II<sub>3</sub>, and III<sub>1</sub>) and in two asymptomatic females (II<sub>1</sub> and III<sub>2</sub>). This mutation was absent in two male family members who did not have a history of symptoms (III<sub>3</sub> and III<sub>4</sub>). Furthermore, the targeted Sanger sequencing did not detect the mutation in 130 adult male controls.</p>
      <p>During the following 2&#xA0;years, the patient maintained the same diet as before surgery. He did not receive any potassium supplement treatment and suffered 12 paralytic attacks. However, there were considerably fewer attacks (monthly in the summer and no attacks in the winter), and the attacks were shorter in duration (2&#x2013;3 hours) than the attacks before adrenalectomy.</p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>Periodic paralysis caused by hypokalaemia possesses significant aetiological heterogeneity. A recent study [<xref ref-type="bibr" rid="CR10">10</xref>] concluded that 42.9% of patients had a secondary cause, including renal tubular acidosis, Gitelman syndrome, thyrotoxicosis, alcoholism, hypothyroidism, Liddle&#x2019;s syndrome, gastroenteritis, and primary hyperaldosteronism. In the other cases of primary periodic paralysis, 48.2% were sporadic and 8.9% had a positive family history [<xref ref-type="bibr" rid="CR10">10</xref>]. Some of the cases with a positive family history might be attributed to mutations in a single gene, such as <italic>CACNA1S</italic> or <italic>SCN4A</italic>.</p>
      <p><italic>CACNA1S</italic> and <italic>SCN4A</italic> encode the human skeletal muscle &#x3B1;1-subunit of a dihydropyridine-sensitive calcium channel and the &#x3B1;-subunit of a sodium channel, respectively [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Previous studies have linked mutations in these genes to HOKPP. The mutant CACNA1S and SCN4A have a partial loss of function, leading to reduced calcium or sodium current density, which is followed by membrane depolarisation. Membrane depolarisation is coupled with the inflow of potassium into skeletal muscle cells, causing paroxysmal hypokalaemia and periodic paralysis [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. In the present case, genetic testing revealed a missense mutation in <italic>CACNA1S</italic>, resulting in p.Arg528Cys. This mutation had not been reported previously. A genotype-phenotype correlation was identified in the patient&#x2019;s family by the cosegregation of the mutation with all of the affected adult male members and a higher penetrance in males. In all of the seven HOKPP1&#x2013;causing mutations that have been reported, two different mutations involve the 528th codon of <italic>CACNA1S</italic>, including p.Arg528His and p.Arg528Gly [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. The arginine residue encoded by the wild-type 528th codon is highly conserved among different species from <italic>C. elegans</italic> to humans, and it is located in the critical voltage sensor region of the transmembrane segment of the calcium channel [<xref ref-type="bibr" rid="CR13">13</xref>]. The above evidence combined with the absence of the mutation in the matched male controls strongly suggests that the Arg528Cys substitution is a novel dominant HOKPP1-causing mutation accounting for the onset of hypokalaemic periodic paralysis in this patient&#x2019;s family.</p>
      <p>The patient also had UAH identified by a CT scan and pathological examination. UAH possesses a pathogenic mechanism distinct from HOKPP; however, the clinical manifestations of the two diseases are similar when UAH causes PA followed by hypokalaemia and muscular paralysis [<xref ref-type="bibr" rid="CR14">14</xref>]. UAH was previously considered a rare subtype of PA [<xref ref-type="bibr" rid="CR15">15</xref>], whereas recent studies suggest that the contribution of UAH to PA might have been underestimated because high-resolution multi-slice CT and other new screening tests have shown more patients with PA to have UAH [<xref ref-type="bibr" rid="CR2">2</xref>]. This finding is encouraging because PA caused by UAH has been confirmed to be surgically correctable by adrenalectomy with excellent long-term results [<xref ref-type="bibr" rid="CR3">3</xref>]. In the present case, the patient did not display PA, but his clinical manifestation was the most severe of his family members with periodic paralysis based on attack frequency and duration. In addition, there was no remission although he was over 43&#xA0;years old, which could not be completely explained by HOKPP1 alone. After adrenalectomy, the symptoms of the patient were significantly relieved, including increased serum potassium concentrations (<italic>t</italic> test, &#x3B1;&#x2009;=&#x2009;0.05: <italic>P</italic>&#x2009;=&#x2009;0.009) between crises and decreased paralytic attack frequency and duration. This observation suggests a close association between the decreased serum potassium caused by UAH and the severity of HOKPP and supports the hypothesis that adrenalectomy may be an effective treatment for relieving the symptoms of patients with both UAH and severe hypokalaemic paralysis resulting from some incurable genetic diseases such as HOKPP and Gitelman syndrome [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR16">16</xref>].</p>
    </sec>
    <sec id="Sec4" sec-type="conclusions">
      <title>Conclusions</title>
      <p>In this first reported case of unilateral adrenal hyperplasia in concurrence with hypokalaemic periodic paralysis, we identified a novel dominant mutation, p.Arg528Cys, of <italic>CACNA1S</italic> causing HOPPK, which is the third known pathogenic mutation involving the 528th code of <italic>CACNA1S</italic>. These results emphasise the importance of CACNA1S Arg528 in maintaining calcium channel function. The prognosis after adrenalectomy suggests that the presence of UAH might increase the severity of hypokalaemic paralysis caused by other diseases. Operative treatment may be a rational choice for relieving the symptoms of hypokalaemic paralysis by increasing serum potassium, even if the UAH does not cause primary aldosteronism or clinical hypokalaemia.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>This study was approved by the Ethics Committee of Clinical Trials and Biomedical Research, West China Hospital, Sichuan University. Written informed consent for reporting results of genetic testing was obtained from the patient and his seven family members. A copy of the written consent is available for review by the Editor of this journal.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>QD and BY cared for the patient. WT and YS performed the genetic testing. YY was responsible for genetic counselling. BY wrote the manuscript. All of the authors discussed the content of the manuscript and approved the final version of the manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>This work was supported by Science and Technology Support Project of Sichuan province (Grant No.2012SZ0025).</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Guo</surname>
              <given-names>XD</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Gong</surname>
              <given-names>RZ</given-names>
            </name>
            <name>
              <surname>Xiong</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Jin</surname>
              <given-names>XB</given-names>
            </name>
          </person-group>
          <article-title>A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia</article-title>
          <source>Int Urol Nephrol</source>
          <year>2014</year>
          <volume>46</volume>
          <fpage>1283</fpage>
          <lpage>1288</lpage>
          <pub-id pub-id-type="doi">10.1007/s11255-013-0614-9</pub-id>
          <pub-id pub-id-type="pmid">24488149</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sigurjonsdottir</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Gronowitz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Andersson</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Eggertsen</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Herlitz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sakinis</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Wangberg</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Johannsson</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study</article-title>
          <source>BMC Endocr Disord</source>
          <year>2012</year>
          <volume>12</volume>
          <fpage>17</fpage>
          <pub-id pub-id-type="doi">10.1186/1472-6823-12-17</pub-id>
          <pub-id pub-id-type="pmid">22958674</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iacobone</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Citton</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Viel</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Boetto</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Bonadio</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Tropea</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mantero</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Fassina</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Nitti</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Favia</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism</article-title>
          <source>Surgery</source>
          <year>2012</year>
          <volume>152</volume>
          <fpage>1248</fpage>
          <lpage>1255</lpage>
          <pub-id pub-id-type="doi">10.1016/j.surg.2012.08.042</pub-id>
          <pub-id pub-id-type="pmid">23158191</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Huang</surname>
              <given-names>YY</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>BR</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>Paralytic myopathy-a leading clinical presentation for primary aldosteronism in Taiwan</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>1996</year>
          <volume>81</volume>
          <fpage>4038</fpage>
          <lpage>4041</lpage>
          <pub-id pub-id-type="pmid">8923857</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elbaz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vale-Santos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jurkat-Rott</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lapie</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ophoff</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Bady</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Links</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Piussan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Vila</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Monnier</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Padberg</surname>
              <given-names>GW</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Feingold</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Guimaraes</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Wintzen</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>van der Hoeven</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Saudubray</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Grunfeld</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Lenoir</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Nivet</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Echenne</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Frants</surname>
              <given-names>RR</given-names>
            </name>
            <name>
              <surname>Fardeau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lehmann-Horn</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder <italic>effect in 16 caucasian families</italic></article-title>
          <source>Am J Hum Genet</source>
          <year>1995</year>
          <volume>56</volume>
          <fpage>374</fpage>
          <lpage>380</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.1320560406</pub-id>
          <pub-id pub-id-type="pmid">7847370</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sternberg</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Maisonobe</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Jurkat-Rott</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nicole</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Launay</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chauveau</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Tabti</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Lehmann-Horn</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hainque</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A</article-title>
          <source>Brain</source>
          <year>2001</year>
          <volume>124</volume>
          <fpage>1091</fpage>
          <lpage>1099</lpage>
          <pub-id pub-id-type="doi">10.1093/brain/124.6.1091</pub-id>
          <pub-id pub-id-type="pmid">11353725</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fontaine</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Vale-Santos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jurkat-Rott</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Reboul</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Plassart</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rime</surname>
              <given-names>CS</given-names>
            </name>
            <name>
              <surname>Elbaz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Heine</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Guimar&#xE3;es</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Weissenbach</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Baumann</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Fardeau</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lehmann-Horn</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families</article-title>
          <source>Nat Genet</source>
          <year>1994</year>
          <volume>6</volume>
          <fpage>267</fpage>
          <lpage>272</lpage>
          <pub-id pub-id-type="doi">10.1038/ng0394-267</pub-id>
          <pub-id pub-id-type="pmid">8012389</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bulman</surname>
              <given-names>DE</given-names>
            </name>
            <name>
              <surname>Scoggan</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>van Oene</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Nicolle</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Hahn</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Tollar</surname>
              <given-names>LL</given-names>
            </name>
            <name>
              <surname>Ebers</surname>
              <given-names>GC</given-names>
            </name>
          </person-group>
          <article-title>A novel sodium channel mutation in a family with hypokalemic periodic paralysis</article-title>
          <source>Neurology</source>
          <year>1999</year>
          <volume>53</volume>
          <fpage>1932</fpage>
          <lpage>1936</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.53.9.1932</pub-id>
          <pub-id pub-id-type="pmid">10599760</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weiner</surname>
              <given-names>ID</given-names>
            </name>
            <name>
              <surname>Wingo</surname>
              <given-names>CS</given-names>
            </name>
          </person-group>
          <article-title>Hypokalemia-consequences, causes, and correction</article-title>
          <source>J Am Soc Nephrol</source>
          <year>1997</year>
          <volume>8</volume>
          <fpage>1179</fpage>
          <lpage>1188</lpage>
          <pub-id pub-id-type="pmid">9219169</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kayal</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Goswami</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Das</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Jain</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Clinical and biochemical spectrum of hypokalemic paralysis in North: East India</article-title>
          <source>Ann Indian Acad Neurol</source>
          <year>2013</year>
          <volume>16</volume>
          <fpage>211</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="doi">10.4103/0972-2327.112469</pub-id>
          <pub-id pub-id-type="pmid">23956566</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morrill</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Cannon</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca2+ channel expressed in Xenopus laevis oocytes</article-title>
          <source>J Physiol</source>
          <year>1999</year>
          <volume>520</volume>
          <fpage>321</fpage>
          <lpage>336</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1469-7793.1999.00321.x</pub-id>
          <pub-id pub-id-type="pmid">10523403</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jurkat-Rott</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Mitrovic</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hang</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kouzmekine</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Iaizzo</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Herzog</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lerche</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nicole</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Vale-Santos</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chauveau</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fontaine</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lehmann-Horn</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>9549</fpage>
          <lpage>9554</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.97.17.9549</pub-id>
          <pub-id pub-id-type="pmid">10944223</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Liao</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Du</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhu</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ren</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Ke</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>Q</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family</article-title>
          <source>J Mol Med (Berl)</source>
          <year>2005</year>
          <volume>83</volume>
          <fpage>203</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="doi">10.1007/s00109-005-0638-4</pub-id>
          <pub-id pub-id-type="pmid">15726306</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kotsaftis</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Savopoulos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Agapakis</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ntaios</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tzioufa</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Papadopoulos</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Fahantidis</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hatzitolios</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report</article-title>
          <source>Cases J</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>6813</fpage>
          <pub-id pub-id-type="doi">10.4076/1757-1626-2-6813</pub-id>
          <pub-id pub-id-type="pmid">19829865</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Amar</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Plouin</surname>
              <given-names>PF</given-names>
            </name>
            <name>
              <surname>Steichen</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2010</year>
          <volume>5</volume>
          <fpage>9</fpage>
          <pub-id pub-id-type="doi">10.1186/1750-1172-5-9</pub-id>
          <pub-id pub-id-type="pmid">20482833</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ng</surname>
              <given-names>HY</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Hsu</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Tsai</surname>
              <given-names>YZ</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>HC</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>CT</given-names>
            </name>
          </person-group>
          <article-title>Hypokalemic paralysis due to Gitelman syndrome: a family study</article-title>
          <source>Neurology</source>
          <year>2006</year>
          <volume>67</volume>
          <fpage>1080</fpage>
          <lpage>1082</lpage>
          <pub-id pub-id-type="doi">10.1212/01.wnl.0000237527.27595.87</pub-id>
          <pub-id pub-id-type="pmid">17000984</pub-id>
        </element-citation>
      </ref>
      <ref-list id="BSec1">
        <title>Pre-publication history</title>
        <ref id="CR17">
          <mixed-citation publication-type="other">The pre-publication history for this paper can be accessed here:<ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2490/14/96/prepub">http://www.biomedcentral.com/1471-2490/14/96/prepub</ext-link></mixed-citation>
        </ref>
      </ref-list>
    </ref-list>
  </back>
</article>
</pmc-articleset>
